Medicure Inc (TSXV:MPH)

C$ 1.02 -0.07 (-6.42%) Market Cap: 10.64 Mil Enterprise Value: 5.05 Mil PE Ratio: 0 PB Ratio: 0.52 GF Score: 73/100

Q1 2024 Medicure Inc Earnings Call Transcript
May 29, 2024

C$1.03

Earnings
Q4 2023 Medicure Inc Earnings Call Transcript
Apr 09, 2024

C$1.08 (+1.89%)

Earnings
Q3 2023 Medicure Inc Earnings Call Transcript
Nov 22, 2023

C$1.45 (-3.33%)

Earnings
Q2 2023 Medicure Inc Earnings Call Transcript
Jul 31, 2023

C$1.46 (+4.29%)

Earnings
Q1 2023 Medicure Inc Earnings Call Transcript
May 29, 2023

C$1.24 (+12.73%)

Earnings
Q4 2022 Medicure Inc Earnings Call Transcript
Apr 10, 2023

C$1.16 (+1.75%)

Earnings
Q3 2022 Medicure Inc Earnings Call Transcript
Nov 25, 2022

C$1.09 (-0.91%)

Earnings
Q2 2022 Medicure Inc Earnings Call Transcript
Aug 25, 2022

C$1.03 (-6.36%)

Earnings
Q1 2022 Medicure Inc Earnings Call Transcript
May 31, 2022

C$1.44 (+20.00%)

Earnings
Q4 2021 Medicure Inc Earnings Call Transcript
Apr 28, 2022

C$0.95 (+14.46%)

Earnings
Q3 2021 Medicure Inc Earnings Call Transcript
Nov 23, 2021

C$1.16 (+10.48%)

Earnings
Q2 2021 Medicure Inc Earnings Call Transcript
Aug 30, 2021

C$1.13

Earnings
Q1 2021 Medicure Inc Earnings Call Transcript
May 11, 2021

C$1.2 (-20.00%)

Earnings
Q3 2020 Medicure Inc Earnings Call Transcript
Nov 12, 2020

C$0.78 (-2.50%)

Earnings
Q2 2020 Medicure Inc Earnings Call Transcript
Aug 12, 2020

C$1.01

Earnings
Q1 2020 Medicure Inc Earnings Call Transcript
May 13, 2020

C$1.08 (-11.48%)

Earnings
Q4 2019 Medicure Inc Earnings Call Transcript
Apr 16, 2020

C$1.85 (-23.24%)

Earnings
Q3 2019 Medicure Inc Earnings Call Transcript
Nov 27, 2019

C$4.83 (-3.98%)

Earnings
Q2 2019 Medicure Inc Earnings Call Transcript
Aug 09, 2019

C$4.61

Earnings
Q1 2019 Medicure Inc Earnings Call Transcript
May 28, 2019

C$5 (-16.53%)

Earnings
Full Year 2018 Medicure Inc Earnings Call Transcript
Apr 30, 2019

C$6.3 (+4.65%)

Earnings

Full Year 2018 Medicure Inc Earnings Call Transcript

Apr 30, 2019 / 12:30PM GMT

Release Date Price: C$6.3 (+4.65%)

Transcript

Operator

Welcome to fiscal year-end 2018 conference call. My name is Sylvia, and I will be your operator for today's call. (Operator Instructions) Please note that this conference is being recorded. I will now turn the call over to Dr. Albert Friesen. Dr. Friesen, you may begin.

Albert David Friesen

Medicure Inc. - Founder, Chairman, CEO & President

Thanks, Sylvia, and good morning to you all. We appreciate your interest and participation on today's call. Joining me on the call is our CFO, James Kinley; and our Vice President Commercial Operations, Kevin Taylor.

For the number of patients using AGGRASTAT, our main drug, continue to increase throughout 2018 to approximately 65% of the patient market by the end of 2018, up from the 63% reported in the third quarter of 2018. The revenue for the quarter ending December 31, 2018, from AGGRASTAT was $8.2 million, which is up from the $7 million revenue recorded Q3 2018. As expected, revenue from Medicure's second drug on the U.S. market, ZYPITAMAG, is still small, as we wait for the various insurance coverages

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.